Global preimplantation genetic diagnosisis market expected to reach USD 96.8 million by 2024, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing incidence of inherited single gene associated and late onset genetic disorders.
Ongoing introduction of advancements in in-vitro fertilization (IVF) methods are key factors that have a positive impact on the growth of this market. Incorporation of novel algorithms pertaining to genetic diagnosis using NGS technology are expected to fuel demand in the coming years.
Demand for successful embryo implantation in couples who are detected with certain chromosomal aberrations or fertility problems are also factors anticipated to boost growth in demand over the forecast period.
Further key findings from the study suggest:
Chromosomal abnormalities accounted for over 36% of the revenue generated in 2015. This large share can be attributed to growing usage of PGD techniques for detection of aneuploidies that are observed in higher aged maternal patients. Furthermore, presence of large product portfolio of different market players operating in chromosomal abnormality detection is responsible for large market share of this technique.
Embryo HLA typing for stem cell therapy accounted for over 32% of the revenue generated in the market for 2015. High incidence rate of single gene disorders and late onset hereditary oncology diseases that need to be treated in order to curb the mortality rate are major driver for growth of this segment.
Embryo implantation for treatment of the first child that is inherited with the chromosomal abnormality by the virtue of ‘savior sibling’ is attributive towards market growth. With expected development of this segment, the market will witness lucrative opportunities of growth over the forecast period.
North America dominated the market in 2015, with revenue estimated at over USD 35 million in 2015. Presence of sophisticated healthcare infrastructure, rising aneuploidy, and infertility rates, favorable government initiatives with respect to genetic diagnosis and its application in IVF are major factors driving growth of this region.
Asia Pacific is expected to witness lucrative growth from 2016 to 2024 due to the availability of cost-effective PGD procedures coupled with rapidly rising healthcare R&D investment, and growing medical expenditures in emerging economies of India and China.
Key participants of the preimplantation genetic diagnosis market include Genesis Genetics, LabCorp, Natera, Quest Diagnostics, Genea, Genzyme Corporation, Reproductive Genetics Institute, and F. Hoffman La Roche Ltd.
These participants are involved in R&D for development of tests that can detect several chromosomal abnormalities using single cell analysis and prevent inheritance of genetic imbalances.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. Esoteric Testing Market Report
The U.S. esoteric testing market size is expected to grow at a CAGR of around 7% during 2020-2026
Advancement in technology such as first-generation genome sequencing and next-generation genome sequencing...
Report Scope The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2019, 2020 and 2025. This report reviews the main sequencing technologies and explains why genetic variation is important...
The global infectious disease diagnostics market size is projected to reach USD 39.8billion by 2026 from USD 28.1billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift...
The veterinary diagnostics market is expected to reach USD 3.9 billion by 2026 from an estimated USD 2.5 billion in 2021, at a CAGR of 9.4%. Market growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising...
Global Endoscopy Capsule Market, By Product Type (Small Bowel, Esophageal, Colon), By Accessories (Wireless Capsule v/s Workstation and Receiver), By Application (Obscure Gastrointestinal Bleeding, Crohn’s Disease, Small Intestine Tumor, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Company, By Region,...
120 pages •
By Infiniti Research Limited
• May 2021
Global Automotive On-board Diagnostics (OBD) Market 2021-2025 The analyst has been monitoring the automotive on-board diagnostics (OBD) market and it is poised to grow by $ 27.63 billion during 2021-2025, progressing at a CAGR of over 17% during the forecast period. Our report on automotive on-board diagnostics (OBD) market...
120 pages •
By Infiniti Research Limited
• Apr 2021
Global Animal Health Diagnostics Market 2021-2025 The analyst has been monitoring the animal health diagnostics market and it is poised to grow by USD 1.78 billion during 2021-2025, progressing at a CAGR of almost 10% during the forecast period. Our report on the animal health diagnostics market provides a holistic analysis,...
The Global Companion Diagnostics Partnering Terms and Agreements 2010-2021 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in companion diagnostics partnering deals Companion...
The multimodal image fusion software market was valued at US$ 298.29 million in 2020 and is projected to reach US$ 552.30 million by 2028; it is expected to grow at a CAGR of 8.1% during 2021–2028. Increasing government and private spending on healthcare infrastructure is a major factor driving the multimodal image fusion software market....
The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field,...
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.